Previous 10 | Next 10 |
home / stock / elv / elv articles
These seven large-cap stocks were the best performers in the last week. Are they in your portfolio? United Airlines Holdings, Inc. (NASDAQ:UA...
Elevance Health Inc. (NYSE:ELV) reported better-than-expected first-quarter earnings and raised its FY23 guidance. Elevance Health reported first-q...
Elevance Health Inc. (NYSE:ELV) reported first-quarter revenues of $42.3 billion, up 0.9% year over year, marginally missing the consensu...
Elevance Health (NYSE:ELV) has outperformed the market over the past 20 years by 5.02% on an annualized basis producing an average annual return of...
The United States stock market opened today to a cautious post-Easter floor as healthcare systems see the brunt of trepidation. The U.S. stock mark...
Elevance Health (NYSE:ELV) has outperformed the market over the past 10 years by 7.31% on an annualized basis producing an average annual return of...
A recent study suggests that despite Novo Nordisk A/S’s (NYSE:NVO) high monthly charge of close to $1,000 for its blockbuster diabe...
Some major U.S. health insurers, including CVS Health Inc (NYSE:CVS), Elevance Health Inc (NYSE:ELV), and Kaiser Permanente wil...
Some major U.S. health insurers, including CVS Health Inc (NYSE:CVS), Elevance Health Inc (NYSE:ELV) and Kaiser Permanente, will start reimburs...
News, Short Squeeze, Breakout and More Instantly...
Elevance Health Inc Com Company Name:
ELV Stock Symbol:
NYSE Market:
Elevance Health Inc Com Website:
2024-07-17 12:00:27 ET Image source: The Motley Fool. Elevance Health (NYSE: ELV) Q2 2024 Earnings Call Jul 17, 2024 , 8:30 a.m. ET Operator Continue reading For further details see: Elevance Health (ELV) Q2 2024 Earnings Call Transcript
Assa Abloy AB ADR (ASAZY) is expected to report for Q2 2024 First Horizon Corporation (FHN) is expected to report $0.37 for Q2 2024 Community Trust Bancorp Inc. (CTBI) is expected to report $1.03 for Q2 2024 Cohen & Steers Inc (CNS) is expected to report for Q2 2024 First Indu...
2Q 2024 operating revenue of $43.2 billion 2Q 2024 adjusted operating gain 1 of $2.8 billion 2Q 2024 diluted EPS 2 of $9.85, up 26%; adjusted diluted EPS 1 of $10.12, up 12% 3Q 2024 dividend of $1.63 per share declared to shareholders Elevance Healt...